Kay Brinkmann

943 total citations
17 papers, 587 citations indexed

About

Kay Brinkmann is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Kay Brinkmann has authored 17 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Kay Brinkmann's work include Cancer Genomics and Diagnostics (6 papers), Immunotherapy and Immune Responses (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Kay Brinkmann is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Immunotherapy and Immune Responses (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Kay Brinkmann collaborates with scholars based in Switzerland, United States and Germany. Kay Brinkmann's co-authors include Johan Skog, Daniel Enderle, Mikkel Noerholm, Paul Chaplin, Ulrike Dirmeier, Alexandra Spiel, Ryan B. Rountree, Stefan Bentink, Mark Suter and Reiner Laus and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Kay Brinkmann

17 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Brinkmann Switzerland 12 415 279 100 72 72 17 587
Emre Basar United States 6 640 1.5× 345 1.2× 125 1.3× 52 0.7× 18 0.3× 8 768
Yukikazu Natori Japan 13 320 0.8× 75 0.3× 94 0.9× 32 0.4× 45 0.6× 14 542
Lee Adam Wheeler United States 8 335 0.8× 47 0.2× 152 1.5× 100 1.4× 45 0.6× 15 592
Navpreet Tung United States 7 443 1.1× 295 1.1× 295 3.0× 21 0.3× 26 0.4× 8 751
Linda Hanlon United Kingdom 12 531 1.3× 110 0.4× 130 1.3× 68 0.9× 51 0.7× 14 773
Mohammed Amarzguioui Norway 13 955 2.3× 330 1.2× 116 1.2× 42 0.6× 14 0.2× 13 1.1k
Celine Prakash Singapore 9 297 0.7× 95 0.3× 193 1.9× 27 0.4× 46 0.6× 14 728
Gang Long China 12 408 1.0× 87 0.3× 90 0.9× 20 0.3× 13 0.2× 18 597
Jewell Walters United States 12 385 0.9× 215 0.8× 233 2.3× 17 0.2× 19 0.3× 17 753

Countries citing papers authored by Kay Brinkmann

Since Specialization
Citations

This map shows the geographic impact of Kay Brinkmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Brinkmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Brinkmann more than expected).

Fields of papers citing papers by Kay Brinkmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Brinkmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Brinkmann. The network helps show where Kay Brinkmann may publish in the future.

Co-authorship network of co-authors of Kay Brinkmann

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Brinkmann. A scholar is included among the top collaborators of Kay Brinkmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Brinkmann. Kay Brinkmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brinkmann, Kay, et al.. (2020). Exploring Online Depression Forums via Text Mining: A Comparison of Reddit and a Curated Online Forum. University of Regensburg Publication Server (University of Regensburg). 70–81. 4 indexed citations
2.
Sanos, Stéphanie L., Barbara Bathke, Kay Brinkmann, et al.. (2018). NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin. Frontiers in Immunology. 8. 1988–1988. 12 indexed citations
3.
Brinkmann, Kay, et al.. (2018). Exosome liquid biopsies of NSCLC patients for longitudinal monitoring of ALK fusions and resistance mutations.. Journal of Clinical Oncology. 36(15_suppl). e24090–e24090. 11 indexed citations
4.
Krug, Anne K., Daniel Enderle, Chris Karlovich, et al.. (2017). Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. Annals of Oncology. 29(3). 700–706. 208 indexed citations
5.
Bathke, Barbara, Maria Hinterberger, Kay Brinkmann, et al.. (2017). CD70 encoded by modified vaccinia virus Ankara enhances CD8 T‐cell‐dependent protective immunity in MHC class II‐deficient mice. Immunology. 154(2). 285–297. 3 indexed citations
6.
Sullivan, Ryan J., Vincent O’Neill, Kay Brinkmann, et al.. (2015). Plasma-based monitoring of BRAF mutations during therapy for malignant melanoma (MM) using combined exosomal RNA and cell-free DNA analysis.. Journal of Clinical Oncology. 33(15_suppl). 9017–9017. 8 indexed citations
7.
Krug, Anne K., Chris Karlovich, Tina Koestler, et al.. (2015). Abstract B136: Plasma EGFR mutation detection using a combined exosomal RNA and circulating tumor DNA approach in patients with acquired resistance to first-generation EGFR-TKIs. Molecular Cancer Therapeutics. 14(12_Supplement_2). B136–B136. 11 indexed citations
8.
Brinkmann, Kay, Daniel Enderle, Alexandra Spiel, et al.. (2015). Detection of EGFR activating and T790M resistance mutations in plasma of lung cancer patients using combined exosomal RNA and cfDNA capture.. Journal of Clinical Oncology. 33(15_suppl). e22156–e22156. 2 indexed citations
9.
Brinkmann, Kay, Daniel Enderle, Tina Koestler, et al.. (2015). Abstract 545: Plasma-based diagnostics for detection of EML4-ALK fusion transcripts in NSCLC patients. Cancer Research. 75(15_Supplement). 545–545. 11 indexed citations
10.
Enderle, Daniel, Kay Brinkmann, Tina Koestler, et al.. (2014). 454 Monitoring therapy response and resistance mutations in circulating RNA and DNA of plasma from patients with malignant melanoma. European Journal of Cancer. 50. 149–149. 2 indexed citations
11.
Schweneker, Marc, Kay Brinkmann, Henning Lauterbach, et al.. (2014). Recombinant Modified Vaccinia Virus Ankara Generating Excess Early Double-Stranded RNA Transiently Activates Protein Kinase R and Triggers Enhanced Innate Immune Responses. Journal of Virology. 88(24). 14396–14411. 17 indexed citations
12.
Lauterbach, Henning, Barbara Bathke, Kay Brinkmann, et al.. (2013). Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity. Frontiers in Immunology. 4. 251–251. 12 indexed citations
13.
Wennier, Sonia, Kay Brinkmann, Ulrike Dirmeier, et al.. (2013). A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses. PLoS ONE. 8(8). e73511–e73511. 24 indexed citations
14.
Rountree, Ryan B., Stefanie Mandl, Kay Brinkmann, et al.. (2011). Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy. Cancer Research. 71(15). 5235–5244. 130 indexed citations
15.
Schweneker, Marc, et al.. (2011). The Vaccinia Virus O1 Protein Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase 1/2 and Promotes Viral Virulence. Journal of Virology. 86(4). 2323–2336. 41 indexed citations
16.
Brinkmann, Kay, Marc Schweneker, Robin Steigerwald, et al.. (2010). Immediate-Early Expression of a Recombinant Antigen by Modified Vaccinia Virus Ankara Breaks the Immunodominance of Strong Vector-Specific B8R Antigen in Acute and Memory CD8 T-Cell Responses. Journal of Virology. 84(17). 8743–8752. 43 indexed citations
17.
Funk, Martin, et al.. (2002). Vector systems for heterologous expression of proteins in Saccharomyces cerevisiae. Methods in enzymology on CD-ROM/Methods in enzymology. 350. 248–257. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026